Cardiologs Holter Platform

by Philips France Commercial  · Based in France → — Reinventing cardiology diagnostics with medical-grade AI and cloud technology.
Cardiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact sales
Regulatory Status Disclosed

Overview

The Cardiologs Holter Platform, powered by Philips, is an AI-driven, cloud-based medical device designed to transform cardiac diagnostics. It leverages deep-learning technology to provide fast and accurate analysis of Holter ECG data, reliably capturing ventricular and atrial rhythms. The platform is intended for use by qualified healthcare professionals for the assessment of arrhythmias, supporting the detection of over 20 types of events, including Atrial Fibrillation, Ventricular Tachycardia, and various blocks. By streamlining ECG analysis, it aims to reduce analysis time by approximately 42% and significantly decrease false positive AF episodes. The Cardiologs Holter Platform is vendor-neutral, supporting recordings from multiple Holter brands and devices, and can integrate with electronic medical record systems via Philips IntelliBridge Enterprise. It offers secure data hosting on ISO/IEC 27001 certified Amazon Web Services servers, ensuring compliance with global data privacy regulations.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered deep learning technology for ECG analysis
  • Cloud-based platform for anytime, anywhere access
  • Vendor-neutral compatibility with multiple Holter devices
  • Reduces Holter analysis time by approximately 42%
  • Detects over 20 types of arrhythmias
  • Integration with Electronic Medical Record (EMR) systems (Philips IntelliBridge Enterprise)
  • Secure data hosting on ISO/IEC 27001 certified AWS servers
  • Generates easy-to-read, automatically enriched reports
  • Improved specificity for Atrial Fibrillation detection (10x fewer false positives)
  • Supports simultaneous access for multiple users

Use Cases

  • Faster and more efficient Holter ECG analysis
  • Accurate detection and diagnosis of cardiac arrhythmias (e.g., AFib, VT)
  • Streamlining cardiac diagnostics workflows for clinicians
  • Remote cardiac monitoring using compatible devices like smartwatches
  • Supporting healthcare providers in managing staff shortages and increasing data burden
  • Pediatric cardiology diagnostics and arrhythmia assessment

What Physicians Need to Know

ECG/EKG Analysis Capability
The Cardiologs Holter Platform provides comprehensive ECG signal processing and analysis, including QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis. It utilizes deep neural network and cloud technology for efficient analysis of continuous ambulatory ECGs, analyzing waveforms holistically to better handle complex patterns.
Arrhythmia Detection Accuracy
The platform is FDA-cleared and CE-marked for arrhythmia assessment. It detects over 20 types of events, including various forms of Atrioventricular Block, Atrial Fibrillation/Flutter, Ventricular Tachycardia, and different types of premature complexes. Studies show a 10x reduction in AF false positives while maintaining similar sensitivity, and a 29% increase in sensitivity for VT detection (97% vs 68%). Its positive predictive value for AFib detection is reported at 91%, with a sensitivity of 97%, outperforming conventional methods.
Cardiac Monitoring Integration
The platform is device-agnostic, supporting ECG data from various compatible devices like Holter monitors, event recorders, 12-lead ambulatory ECGs, smartwatches, and ECG patches. It can electronically interface with other computer-based ECG systems, such as ECG management systems, and offers an API for direct data upload.
AHA/ACC Guideline Alignment
The Cardiologs Holter Platform is a medical device that is CE-marked in Europe and FDA-cleared in the United States, indicating adherence to regulatory standards for medical devices.
Physician Tip

The Cardiologs Holter Platform is designed to significantly streamline Holter analysis, potentially reducing analysis time by approximately 42% and minimizing manual editing. Its cloud-based nature facilitates remote access, seamless collaboration among healthcare professionals, and ensures frequent automatic updates. Physicians should note that while the platform provides advanced AI-driven analysis and easy-to-read reports with arrhythmia illustrations, its interpretation results are intended as advisory support and should always be used in conjunction with their clinical expertise, patient history, and other diagnostic information. The platform is suitable for arrhythmia assessment in both adult and pediatric populations, with specific age restrictions (over 18 years) in the US and Australia.

The Cardiologs Holter Platform is highly versatile due to its vendor-neutral design, ensuring compatibility with ECG recordings from a wide array of devices, including various Holter brands, event recorders, 12-lead ambulatory ECG devices, smartwatches, and ECG patches. It offers an Application Programming Interface (API) for direct and automatic digital ECG file uploads to its secure, cloud-hosted databases. Furthermore, it can integrate with electronic medical record (EMR) systems, for example, through the Philips IntelliBridge Enterprise (IBE) solution, to enhance workflow and patient data management. Data security and privacy are maintained with compliance to regulations like GDPR and HIPAA, with data hosted on ISO/IEC 27001 certified AWS servers.

Details

Category Cardiology AI
Pricing Contact sales — Pay per ECG regardless the number of users.
DeploymentCloud-based (SaaS)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The Cardiologs Holter Platform is cleared by the FDA under 510(k) (K250569). It was the first AI solution approved by the FDA for ECG analysis in 2017 and received expanded clearance for pediatric use in 2021.
Integrations
EHR Not specified
Specialties Cardiology

What the Web Says

The Cardiologs Holter Platform is generally well-received, particularly for its AI-powered analysis and efficiency in processing ECG data. Physicians appreciate its ability to reduce manual review time and improve diagnostic accuracy, while healthcare IT values its cloud-based nature and integration capabilities. Some users have noted a learning curve and occasional issues with specific integrations.

Overall: Positive

Strengths

  • AI-powered analysis significantly reduces review time
  • High accuracy in detecting arrhythmias
  • Cloud-based platform offers flexibility and accessibility
  • User-friendly interface for physicians
  • Scalable solution for various practice sizes
  • Improved workflow efficiency and diagnostic turnaround

Limitations

  • Initial learning curve for new users
  • Occasional integration challenges with existing EMR systems
  • Reliance on internet connectivity for cloud access
  • Some users desire more customization options for reports
  • Potential cost for smaller practices
  • Limited direct feedback on specific minor bugs from all sources

Based on reviews from: G2, Capterra, Healthcare IT News, Physician forums/reviews, Medical technology publications

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Cardiologs Holter Platform

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
Cardiologs' AI Receives 510(k) Clearance for Pediatric Use
Cardiologs announced it received 510(k) clearance from the FDA to use its AI-powered cardiac diagnostics platform for pediatric cardiology, based on an improved deep learning algorithm. This expanded authorization allows clinicians to use the technology with confidence in children under 18.
2021-11
PR Newswire
New Study Shows Cardiologs' Deep Learning AI Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Arrhythmias
A clinical study demonstrated that Cardiologs' deep learning AI outperforms the Apple Watch ECG algorithm in detecting atrial arrhythmias, increasing sensitivity by 34% and reducing unclassified readings. This advancement promises benefits for both patients and healthcare professionals.
2021-11
PR Newswire
Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring
Cardiologs launched Cardiologs RPM, a new solution that enables the use of smartwatches for remote cardiac patient monitoring. This platform aims to address the lack of data integration into clinical workflows and streamline data sharing and review.
2021-07
PR Newswire
Study Demonstrates Cardiologs' AI Can Predict Occurrence of Atrial Fibrillation in the Near Future
New research published in the European Heart Journal - Digital Health shows Cardiologs' deep learning model can predict the short-term risk of atrial fibrillation from 24-hour Holter recordings. This study highlights the potential of AI in enhancing monitoring capabilities and enabling proactive treatment.
2022-06
BioWorld MedTech
BioWorld MedTech Patent Highlights: Week 6
This article mentions that Cardiologs Holter Platform is built on over 20 million ECG recordings, is CE-Marked, and FDA cleared for 14 cardiac arrhythmias. It also notes Royal Philips' acquisition of Cardiologs in November 2021.
2022-02
Circulation: Arrhythmia and Electrophysiology (American Heart Association Journals)
Deep Learning Can Unmask Conduction Tissue Disease From an Ambulatory ECG
A study published in Circulation: Arrhythmia and Electrophysiology, utilizing data from the Cardiologs Holter platform, demonstrates that deep learning can effectively unmask conduction tissue disease from ambulatory ECGs. The model achieved high accuracy in predicting asystolic pauses.
2025-08
FDA
510(k) Premarket Notification - K212112
This FDA 510(k) clearance document details the Cardiologs Holter Platform's intended use for qualified healthcare professionals to assess arrhythmias using ECG data in adult and pediatric populations. It outlines the platform's capabilities in ECG signal processing, QRS detection, and rhythm analysis.
2022-01
Innolitics
2025 Year in Review: Cardiology AI/ML SaMD 510(k) Clearances
This review of 2025 cardiology AI/ML clearances includes the Philips France Commercial Cardiologs Holter Platform (K250569) as a traditional 510(k) clearance in cardiovascular devices. It highlights the growing trend of AI/ML in cardiology.
2026-01

Videos

Product demos, reviews, and walkthroughs for Cardiologs Holter Platform.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

The Cardiologs Holter Platform uses deep neural networks (DNNs) to automatically analyze ECG data, detecting over 20 cardiac arrhythmias. Studies show it is non-inferior to conventional analysis, often faster, and can have higher sensitivity for certain arrhythmias like AFib and ventricular tachycardia, while reducing false positives.
Yes, the Cardiologs Holter Platform is FDA cleared (initially in 2017, with expanded clearance for pediatric use in 2021) and CE marked in Europe. It is intended for use by qualified healthcare professionals for arrhythmia assessment using ECG data in both adult and pediatric populations.
While the AI provides robust analysis, its interpretation results are not intended to be the sole means of diagnosis; they are advisory. Physicians retain the critical role of reviewing, verifying, and adjusting AI-generated annotations in conjunction with their clinical expertise, patient history, and other diagnostic information.
Alternatives include traditional Holter analysis platforms, mobile cardiac telemetry (MCT) devices, patch-based monitors, and other AI-powered ECG analysis solutions. Cardiologs differentiates itself through its medical-grade AI, cloud-based vendor-neutrality, and demonstrated efficiency in reducing analysis time and false positives.
The platform is cloud-based and vendor-neutral, allowing compatibility with various recording formats and access from any internet-connected computer. It supports integration with EHR/EMR systems and offers APIs for automated data exchange, aiming to streamline workflows and reduce manual effort.
While specific pricing isn't publicly detailed, Cardiologs operates on a Software-as-a-Service (SaaS) model, often with a 'pay per ECG' structure regardless of the number of users. Factors influencing cost typically include the volume of analyses, integration needs, and potentially additional services or support.
Holter recordings are uploaded through a secured/encrypted connection to Cardiologs' secured hosting databases, which are designed to be HIPAA compliant. As a cloud-based medical device, it adheres to regulatory standards for health data protection.

Compare Cardiologs Holter Platform

VS
Cardiologs Holter Platform vs iPredict Eye Screening
Cardiology AI Adjacent · 65/100
Cardiologs Holter Platform is an AI-powered, cloud-based solution specifically designed for fast and accurate Holter ECG analysis to detect arrhythmias. iPredict Eye Screening, while also AI-powered and cloud-based,…
VS
Cardiologs Holter Platform vs EchoNext
Cardiology AI Adjacent · 75/100
Both tools leverage AI for cardiac diagnostics and are FDA-cleared and HIPAA-compliant. Cardiologs Holter Platform focuses on comprehensive arrhythmia detection from Holter ECGs, aiming to streamline analysis for…
VS
Cardiologs Holter Platform vs PMcardio
Cardiology AI Adjacent · 75/100
Both Cardiologs Holter Platform and PMcardio offer AI-powered ECG analysis for cardiac conditions, making them adjacent competitors. Cardiologs focuses on streamlining Holter ECG analysis for over 20 types…
VS
Cardiologs Holter Platform vs Sleepiz One+
Cardiology AI Adjacent · 65/100
While both tools leverage AI for cardiac monitoring and are FDA-cleared, their primary applications differ significantly. Cardiologs Holter Platform is designed for in-depth, diagnostic analysis of Holter ECG…

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.